메뉴 건너뛰기
Annals of Hematology
Volumn 93, Issue 8, 2014, Pages 1439-1440
Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis
Author keywords

[No Author keywords available]
Indexed keywords

ANTIFUNGAL AGENT; VEMURAFENIB;
EID: 84904751475     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1987-7     Document Type: Letter
Times cited : (22)
References (8)
  • 1
    • 79959293462 scopus 로고    scopus 로고
    • Braf mutations in hairy-cell leukemia
    • Tiacci E, Trifonov V, Schiavon G et al (2011) Braf mutations in hairy-cell leukemia. N Engl J Med 364:2305-2315
    • (2011) N Engl J Med , vol.364 , pp. 2305-2315
    • Tiacci, E.1    Trifonov, V.2    Schiavon, G.3
  • 2
    • 84861417677 scopus 로고    scopus 로고
    • Braf inhibition in refractory hairy-cell leukemia
    • Dietrich S, Glimm H, Andrulis M et al (2012) Braf inhibition in refractory hairy-cell leukemia. N Engl J Med 366:2038-2040
    • (2012) N Engl J Med , vol.366 , pp. 2038-2040
    • Dietrich, S.1    Glimm, H.2    Andrulis, M.3
  • 3
    • 84875340204 scopus 로고    scopus 로고
    • Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a v600e mutation
    • Peyrade F, Re D, Ginet C et al (2013) Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a v600e mutation. Haematologica 98:e20-e22
    • (2013) Haematologica , vol.98
    • Peyrade, F.1    Re, D.2    Ginet, C.3
  • 4
    • 84875055512 scopus 로고    scopus 로고
    • Rapid response of biallelic braf v600e mutated hairy cell leukaemia to low dose vemurafenib
    • Follows G, Sims H, Bloxham D et al (2013) Rapid response of biallelic braf v600e mutated hairy cell leukaemia to low dose vemurafenib. Br J Haematol 161:150-153
    • (2013) Br J Haematol , vol.161 , pp. 150-153
    • Follows, G.1    Sims, H.2    Bloxham, D.3
  • 5
    • 84883875497 scopus 로고    scopus 로고
    • Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a braf mutation
    • Munoz J, Schlette E, Kurzrock R (2013) Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a braf mutation. J Clin Oncol 31:e351-e352
    • (2013) J Clin Oncol , vol.31
    • Munoz, J.1    Schlette, E.2    Kurzrock, R.3
  • 6
    • 79952003197 scopus 로고    scopus 로고
    • Raf inhibition and induction of cutaneous squamous cell carcinoma
    • Robert C, Arnault JP, Mateus C (2011) Raf inhibition and induction of cutaneous squamous cell carcinoma. Curr Opin Oncol 23:177-182
    • (2011) Curr Opin Oncol , vol.23 , pp. 177-182
    • Robert, C.1    Arnault, J.P.2    Mateus, C.3
  • 7
    • 84863463901 scopus 로고    scopus 로고
    • Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective braf inhibition
    • Zimmer L, Hillen U, Livingstone E et al (2012) Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective braf inhibition. J Clin Oncol 30:2375-2383
    • (2012) J Clin Oncol , vol.30 , pp. 2375-2383
    • Zimmer, L.1    Hillen, U.2    Livingstone, E.3
  • 8
    • 84883062033 scopus 로고    scopus 로고
    • Continued response off treatment after braf inhibition in refractory hairy cell leukemia
    • Dietrich S, Hüllein S, Hundemer M et al (2013) Continued response off treatment after braf inhibition in refractory hairy cell leukemia. J Clin Oncol 31:e300-e303
    • (2013) J Clin Oncol , vol.31
    • Dietrich, S.1    Hüllein, S.2    Hundemer, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.